"GO.ID","Term","Annotated","Significant","Expected","Rank.in.p.value_classic","p.value_elim","p.value_classic","genes"
"GO:0010842","retina layer formation",19,2,0.05,1,0.00029,0.0012,"RDH13,TFAP2B"
"GO:0034308","primary alcohol metabolic process",72,2,0.19,4,0.00417,0.016,"ADH1C,RDH13"
"GO:0072505","divalent inorganic anion homeostasis",10,1,0.03,5,0.01336,0.0266,"TFAP2B"
"GO:0072506","trivalent inorganic anion homeostasis",10,1,0.03,6,0.01336,0.0266,"TFAP2B"
"GO:1990440","positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress",10,1,0.03,7,0.01336,0.0266,"ATF6B"
"GO:0061983","meiosis II cell cycle process",10,1,0.03,8,0.01336,0.0266,"HORMAD2"
"GO:0072044","collecting duct development",10,1,0.03,9,0.01336,0.0266,"TFAP2B"
"GO:0033141","positive regulation of peptidyl-serine phosphorylation of STAT protein",10,1,0.03,10,0.01336,0.0266,"IFNA5"
"GO:0036500","ATF6-mediated unfolded protein response",10,1,0.03,11,0.01336,0.0266,"ATF6B"
"GO:0002523","leukocyte migration involved in inflammatory response",10,1,0.03,12,0.01336,0.0266,"S100A8"
"GO:0055062","phosphate ion homeostasis",10,1,0.03,13,0.01336,0.0266,"TFAP2B"
"GO:0007135","meiosis II",10,1,0.03,14,0.01336,0.0266,"HORMAD2"
"GO:0002002","regulation of angiotensin levels in blood",10,1,0.03,15,0.01336,0.0266,"MME"
"GO:1900102","negative regulation of endoplasmic reticulum unfolded protein response",11,1,0.03,16,0.01468,0.0292,"ATF6B"
"GO:0072017","distal tubule development",11,1,0.03,17,0.01468,0.0292,"TFAP2B"
"GO:0010960","magnesium ion homeostasis",11,1,0.03,18,0.01468,0.0292,"TFAP2B"
"GO:1902514","regulation of calcium ion transmembrane transport via high voltage-gated calcium channel",11,1,0.03,19,0.01468,0.0292,"CACNG1"
"GO:0006069","ethanol oxidation",11,1,0.03,20,0.01468,0.0292,"ADH1C"
"GO:0072578","neurotransmitter-gated ion channel clustering",11,1,0.03,21,0.01468,0.0292,"SHISA7"
"GO:0033139","regulation of peptidyl-serine phosphorylation of STAT protein",12,1,0.03,23,0.01601,0.0318,"IFNA5"
"GO:0070486","leukocyte aggregation",12,1,0.03,24,0.01601,0.0318,"S100A8"
"GO:0090399","replicative senescence",12,1,0.03,25,0.01601,0.0318,"MME"
"GO:1901626","regulation of postsynaptic membrane organization",12,1,0.03,26,0.01601,0.0318,"SHISA7"
"GO:0017014","protein nitrosylation",13,1,0.03,27,0.01733,0.0344,"S100A8"
"GO:0018119","peptidyl-cysteine S-nitrosylation",13,1,0.03,28,0.01733,0.0344,"S100A8"
"GO:0009642","response to light intensity",13,1,0.03,29,0.01733,0.0344,"RDH13"
"GO:0046500","S-adenosylmethionine metabolic process",13,1,0.03,30,0.01733,0.0344,"MAT1A"
"GO:0021794","thalamus development",13,1,0.03,31,0.01733,0.0344,"FOXB1"
"GO:0051238","sequestering of metal ion",13,1,0.03,32,0.01733,0.0344,"S100A8"
"GO:0061577","calcium ion transmembrane transport via high voltage-gated calcium channel",13,1,0.03,33,0.01733,0.0344,"CACNG1"
"GO:0048172","regulation of short-term neuronal synaptic plasticity",13,1,0.03,34,0.01733,0.0344,"SHISA7"
"GO:0050890","cognition",268,3,0.72,35,0.00533,0.0351,"FOXB1,HLA-DRA,SHISA7"
"GO:0040033","negative regulation of translation, ncRNA-mediated",14,1,0.04,36,0.01865,0.037,"AGO3"
"GO:0035810","positive regulation of urine volume",14,1,0.04,37,0.01865,0.037,"TFAP2B"
"GO:0035278","miRNA mediated inhibition of translation",14,1,0.04,38,0.01865,0.037,"AGO3"
"GO:0000098","sulfur amino acid catabolic process",14,1,0.04,39,0.01865,0.037,"MAT1A"
"GO:0045974","regulation of translation, ncRNA-mediated",14,1,0.04,40,0.01865,0.037,"AGO3"
"GO:0031054","pre-miRNA processing",15,1,0.04,41,0.01997,0.0396,"AGO3"
"GO:0021854","hypothalamus development",16,1,0.04,42,0.02129,0.0421,"FOXB1"
"GO:0001991","regulation of systemic arterial blood pressure by circulatory renin-angiotensin",16,1,0.04,43,0.02129,0.0421,"MME"
"GO:0042501","serine phosphorylation of STAT protein",16,1,0.04,44,0.02129,0.0421,"IFNA5"
"GO:0009416","response to light stimulus",294,3,0.79,45,0.00688,0.0443,"FOXB1,MME,RDH13"
"GO:0060644","mammary gland epithelial cell differentiation",17,1,0.05,46,0.0226,0.0447,"FOXB1"
"GO:0006555","methionine metabolic process",17,1,0.05,47,0.0226,0.0447,"MAT1A"
"GO:1900273","positive regulation of long-term synaptic potentiation",17,1,0.05,48,0.0226,0.0447,"SHISA7"
"GO:0048485","sympathetic nervous system development",17,1,0.05,49,0.0226,0.0447,"TFAP2B"
"GO:0061377","mammary gland lobule development",18,1,0.05,50,0.02392,0.0473,"FOXB1"
"GO:0060749","mammary gland alveolus development",18,1,0.05,51,0.02392,0.0473,"FOXB1"
"GO:0010224","response to UV-B",18,1,0.05,52,0.02392,0.0473,"MME"
"GO:0002544","chronic inflammatory response",18,1,0.05,53,0.02392,0.0473,"S100A8"
"GO:0035809","regulation of urine volume",19,1,0.05,55,0.02523,0.0499,"TFAP2B"
"GO:0009068","aspartate family amino acid catabolic process",19,1,0.05,56,0.02523,0.0499,"MAT1A"
"GO:0097242","amyloid-beta clearance",19,1,0.05,57,0.02523,0.0499,"MME"
"GO:1901685","glutathione derivative metabolic process",19,1,0.05,58,0.02523,0.0499,"GSTT2B"
"GO:1901687","glutathione derivative biosynthetic process",19,1,0.05,59,0.02523,0.0499,"GSTT2B"
